Feed GRFS
GR
Grifols
GRFS · NASDAQ
$7.88 +0.45% (+$0.04)
1M +1.25%
Market Cap 5.8B €
P/E Ratio 15.67x
Div. Yield 3.43%
ROE 6.81%
Bulios Fair Price
$137.15
1640.5% upside
Aktuální cena
$7.88
Podhodnoceno Férová hodnota Nadhodnoceno
Valuation
79 /100
Cheap EV/EBITDA 9.66x
P/S 0.78x
P/B 1.12x
Growth
63 /100
Stable Rev. growth 6.02%
Book val. growth 2.29%
EPS growth 22.51%
Profitability
48 /100
Moderate Net margin 4.96%
Op. margin 18.26%
FCF margin 11.32%
Quality
9 /100
Poor ROE 6.81%
ROA 1.87%
Asset turnover 0.38x
Debt
19 /100
High Current ratio 2.48x
Int. coverage 2.58x
Net debt/EBITDA 5.88x
Stability
58 /100
Moderate Rev. volatility 5.13%
EPS volatility 128.61%
Profitable years 6
Zeptejte se StockBota na GRFS
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jose Ignacio Abia Buenache
Employees
23,833
Headquarters
Barcelona
Nadcházející události
28 ČVC
Earnings
Upcoming earnings report